Search

everythinglearnresearchcommunity

for

Search:↓

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

New compounds may help treat prostate issues without affecting androgen receptors.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Canine hair follicle cells metabolize DHEA and testosterone differently than human cells.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

A man had bad reactions to a hair loss treatment called DNCB.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Researchers made two new compounds that could be used for medicine.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Cedrol nanoemulsions effectively treat hair loss by promoting hair growth and reducing DHT levels safely.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Human hair follicles can process steroid hormones like DHEA.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.